These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 24162628)
1. Variation in the use of medicines by ethnicity during 2006/07 in New Zealand: a preliminary analysis. Metcalfe S; Laking G; Arnold J N Z Med J; 2013 Oct; 126(1384):14-41. PubMed ID: 24162628 [TBL] [Abstract][Full Text] [Related]
2. Does mortality vary between pacific groups in New Zealand? Estimating Samoan, Cook Island Maori, Tongan, and Niuean mortality rates using hierarchical Bayesian modelling. Blakely T; Richardson K; Young J; Callister P; Didham R N Z Med J; 2009 Dec; 122(1307):18-29. PubMed ID: 20148041 [TBL] [Abstract][Full Text] [Related]
3. Te Wero tonu-the challenge continues: Māori access to medicines 2006/07-2012/13 update. Metcalfe S; Beyene K; Urlich J; Jones R; Proffitt C; Harrison J; Andrews Ā N Z Med J; 2018 Nov; 131(1485):27-47. PubMed ID: 30408816 [TBL] [Abstract][Full Text] [Related]
4. Antidepressant dispensing trends in New Zealand between 2004 and 2007. Exeter D; Robinson E; Wheeler A Aust N Z J Psychiatry; 2009 Dec; 43(12):1131-40. PubMed ID: 20001412 [TBL] [Abstract][Full Text] [Related]
5. Does access to medicines differ by gender? Evidence from 15 low and middle income countries. Stephens P; Ross-Degnan D; Wagner AK Health Policy; 2013 Apr; 110(1):60-6. PubMed ID: 23422029 [TBL] [Abstract][Full Text] [Related]
6. Cardiovascular risk management at a Maori-led Primary Health Organisation--findings from a cross-sectional audit. Peiris D; Murray J; Scully D; Tilakawardene V; Hetaraka-Stevens L; Stewart T; Patel A N Z Med J; 2008 Nov; 121(1285):35-46. PubMed ID: 19079435 [TBL] [Abstract][Full Text] [Related]
7. Self-monitoring blood glucose test strip use with diabetes medicines in people with types 1 and 2 diabetes in New Zealand. Metcalfe S; Moodie P; Norris H; Rasiah D N Z Med J; 2014 Nov; 127(1406):48-62. PubMed ID: 25447249 [TBL] [Abstract][Full Text] [Related]
8. Inequity in dialysis related practices and outcomes in Aotearoa/New Zealand: a Kaupapa Māori analysis. Huria T; Palmer S; Beckert L; Williman J; Pitama S Int J Equity Health; 2018 Feb; 17(1):27. PubMed ID: 29458366 [TBL] [Abstract][Full Text] [Related]
9. Access and society as determinants of ischaemic heart disease in indigenous populations. Curtis E; Harwood M; Riddell T; Robson B; Harris R; Mills C; Reid P Heart Lung Circ; 2010; 19(5-6):316-24. PubMed ID: 20444647 [TBL] [Abstract][Full Text] [Related]
10. Equity in statin use in New Zealand. Norris P; Horsburgh S; Becket G; Keown S; Arroll B; Lovelock K; Crampton P; Cumming J; Herbison P J Prim Health Care; 2014 Mar; 6(1):17-22. PubMed ID: 24624407 [TBL] [Abstract][Full Text] [Related]
11. The effect of removing funding restrictions for atorvastatin differed across sociodemographic groups among New Zealanders hospitalised with cardiovascular disease: a national data linkage study. Mehta S; Wells S; Jackson R; Harrison J; Kerr A N Z Med J; 2016 Oct; 129(1443):18-29. PubMed ID: 27736849 [TBL] [Abstract][Full Text] [Related]
12. Sibutramine usage in New Zealand: an analysis of prescription data by the Intensive Medicines Monitoring Programme. Hill GR; Ashton J; Harrison-Woolrych M Pharmacoepidemiol Drug Saf; 2007 Nov; 16(11):1217-26. PubMed ID: 17661435 [TBL] [Abstract][Full Text] [Related]
13. Unlocking the numerator-denominator bias. II: Adjustments to mortality rates by ethnicity and deprivation during 1991-94. The New Zealand Census-Mortality Study. Blakely T; Kiro C; Woodward A N Z Med J; 2002 Feb; 115(1147):43-8. PubMed ID: 11942514 [TBL] [Abstract][Full Text] [Related]
14. IDI trends in antidepressant dispensing to New Zealand children and young people between 2007/08 and 2015/16. Bowden N; Gibb S; Thabrew H; Audas R; Camp J; Taylor B; Hetrick S N Z Med J; 2019 Nov; 132(1505):48-61. PubMed ID: 31697663 [TBL] [Abstract][Full Text] [Related]
15. Sore throat management in New Zealand general practice. Kljakovic M; Crampton P N Z Med J; 2005 Aug; 118(1220):U1609. PubMed ID: 16132070 [TBL] [Abstract][Full Text] [Related]
16. Effect of age, gender, ethnicity, socioeconomic status and region on dispensing of CVD secondary prevention medication in New Zealand: the Atlas of Health Care Variation CVD cohort (VIEW-1). Kerr A; Exeter D; Hanham G; Grey C; Zhao J; Riddell T; Lee M; Jackson R; Wells S N Z Med J; 2014 Aug; 127(1400):39-69. PubMed ID: 25145366 [TBL] [Abstract][Full Text] [Related]
17. Ethnicity and access to prescription medicines. Horsburgh S; Norris P N Z Med J; 2013 Oct; 126(1384):7-11. PubMed ID: 24162626 [No Abstract] [Full Text] [Related]
18. Ethnic differences in the prevalence of new and known diabetes mellitus, impaired glucose tolerance, and impaired fasting glucose. Diabetes Heart and Health Survey (DHAH) 2002-2003, Auckland New Zealand. Sundborn G; Metcalf P; Scragg R; Schaaf D; Dyall L; Gentles D; Black P; Jackson R N Z Med J; 2007 Jun; 120(1257):U2607. PubMed ID: 17632597 [TBL] [Abstract][Full Text] [Related]
19. Characteristics of ovarian cancer in women residing in Aotearoa, New Zealand: 1993-2004. Firestone RT; Wong KC; Ellison-Loschmann L; Pearce N; Jeffreys M J Epidemiol Community Health; 2009 Oct; 63(10):814-9. PubMed ID: 19574244 [TBL] [Abstract][Full Text] [Related]
20. Ethnic disparities in community antibacterial dispensing in New Zealand, 2015. Whyler N; Tomlin A; Tilyard M; Thomas M N Z Med J; 2018 Aug; 131(1480):50-60. PubMed ID: 30116065 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]